DIN 02446634 — OPDIVO 10 MG
OPDIVO is a solution of Nivolumab marketed by BRISTOL-MYERS SQUIBB CANADA. The full Nivolumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02446634
- Brand name
- OPDIVO
- Active ingredient
- Nivolumab
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- PD-1 immune checkpoint inhibitor (anti-PD-1 monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nivolumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02446626 | OPDIVO | 10 MG | SOLUTION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02557320 | OPDIVO SC | 120 MG | SOLUTION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |